These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6441403

  • 1. [Effect of retabolyl on the dynamics of urinary catecholamine and DOPA excretion and electroneuromyographic indices in patients with Duchenne's myodystrophy].
    Badalian LO, Temin PA, Amanova ZN, Avakian GN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1630-5. PubMed ID: 6441403
    [Abstract] [Full Text] [Related]

  • 2. [Effect of the test with the drug Nakom on the dynamics of excretion of catecholamines and DOPA in children with Duchenne's progressive muscular dystrophy].
    Badalian LO, Temin PA, Grinio ZN, Amanova ZN, Sadovskaia IuE.
    Pediatriia; 1985 May; (5):54-5. PubMed ID: 3931050
    [No Abstract] [Full Text] [Related]

  • 3. [Course of Duchenne muscular dystrophy and its treatment].
    Kavtaradze NP, Mindadze BA, Natriashvili GD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 May; 86(11):1638-41. PubMed ID: 3811724
    [Abstract] [Full Text] [Related]

  • 4. [Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
    Badalian LO, Temin PA, Dzhabarov BD, Bespalova VA, Kret LA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 May; 84(3):339-42. PubMed ID: 6426220
    [Abstract] [Full Text] [Related]

  • 5. The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution.
    Dalmaz Y, Peyrin L, Mamelle JC, Tuil D, Gilly R, Cier JF.
    J Neural Transm; 1979 May; 46(1):17-34. PubMed ID: 501348
    [Abstract] [Full Text] [Related]

  • 6. [Steroid treatment of Duchenne's muscular dystrophy].
    Luz Aviles C, Gutiérrez C, Novoa F, Gil E, Stuardo A.
    Rev Chil Pediatr; 1982 May; 53(3):187-91. PubMed ID: 6760264
    [No Abstract] [Full Text] [Related]

  • 7. [Electromyographic changes in Duchenne's form of progressive muscular dystrophy].
    Emeryk B.
    Neurol Neurochir Psychiatr Pol; 1966 Nov; 16(11):1251-6. PubMed ID: 5974576
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H, Keresztes L, Stenzel K.
    Minerva Med; 1968 Dec 12; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract] [Full Text] [Related]

  • 9. [Xeroradiographic examination in the study of Duchenne's progressive muscular dystrophy. Correlation of the radiological data with the clinical and laboratory findings].
    Calandi C, Adami Lami Conti C, Fronzoni S, Nistri R, Rossini F, Aulisi A.
    Minerva Pediatr; 1980 Mar 15; 32(5):283-9. PubMed ID: 7382944
    [No Abstract] [Full Text] [Related]

  • 10. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P, Nowak I, Niebrój-Dobosz I.
    Mater Med Pol; 1994 Mar 15; 26(3):101-4. PubMed ID: 7603078
    [Abstract] [Full Text] [Related]

  • 11. [Discriminant analysis of methods for detecting the heterozygote carrier state for the Duchenne muscular dystrophy gene].
    Khrennikov VIu, Sitnikov VF, Deev AI, Svintsitskiĭ IV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Mar 15; 88(11):14-8. PubMed ID: 3223151
    [Abstract] [Full Text] [Related]

  • 12. [Early and late results of treatment with anabolic steroids of progressive muscular dystrophy].
    Zwoździak W, Zgorzalewicz B.
    Neurol Neurochir Pol; 1967 Mar 15; 1(3):345-51. PubMed ID: 6055670
    [No Abstract] [Full Text] [Related]

  • 13. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy.
    Pacold I, Morgan J, Cohen L.
    Clin Genet; 1975 Mar 15; 7(5):435-41. PubMed ID: 807447
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of fine neuromuscular control in Duchenne's progressive muscular dystrophy I. A basic and clinical study in the rehabilitation of 10 non-ambulatory patients].
    Simard T.
    Union Med Can; 1982 Jun 15; 111(6):569-74. PubMed ID: 7112753
    [No Abstract] [Full Text] [Related]

  • 15. [Duchenne's infantile progressive muscular dystrophy].
    Dubois B.
    Lille Med; 1971 Oct 15; 16(8):1160-77. PubMed ID: 4941183
    [No Abstract] [Full Text] [Related]

  • 16. [Use of molecular and genetic approaches in prenatal diagnosis and prevention of hemophilia A and Duchenne muscular dystrophy].
    Baranov VS, Aseev MV, Gorbunova VN, Ivashchenko TE, Mikhaĭlov AV, Gornostaeva NI, Surin VL.
    Akush Ginekol (Mosk); 1990 Nov 15; (11):26-8. PubMed ID: 2077907
    [Abstract] [Full Text] [Related]

  • 17. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A.
    S Afr Med J; 1982 Nov 13; 62(21):765-7. PubMed ID: 7135141
    [Abstract] [Full Text] [Related]

  • 18. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.
    Sancho S, Mongini T, Tanji K, Tapscott SJ, Walker WF, Weintraub H, Miller AD, Miranda AF.
    N Engl J Med; 1993 Sep 23; 329(13):915-20. PubMed ID: 8361505
    [Abstract] [Full Text] [Related]

  • 19. [The effect of osteochin on the dynamics of the course of the myodystrophic process].
    Temin PA, Nikanorova MIu, Kamennykh LN, Mizitova AM, Aleksandrovskiĭ VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992 Sep 23; 92(3):31-2. PubMed ID: 1332324
    [Abstract] [Full Text] [Related]

  • 20. The course of aversive conditioning related to the excretion of catecholamines, DOPA and their oxidoreduction states.
    Dostálek C, Jokl J, Koch E, Krása H.
    Physiologie; 1980 Sep 23; 17(1):45-56. PubMed ID: 6767255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.